Alessandra Di Bacco

3PUBLICATIONS
17CO-AUTHORS
Gene and molecular therapyPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 29, 2021
Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration.

Kenneth C Anderson, Daniel Auclair, Stacey J Adam

|Mar 08, 2020
c-MYC expression and maturity phenotypes are associated with outcome benefit from addition of ixazomib to lenalidomide-dexamethasone in myeloma.

Alessandra Di Bacco, Nizar J Bahlis, Nikhil C Munshi

Pageof 1